Estrella Immunopharma, Inc. (ESLA) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 2.18M | 613.2K | 4.8M | 5.54M | 2.1M | 1.05M | 3.38M | 3.95M | 469.53K | 1.02M | 1.87M | 169.24K | 149.65K | 2.76M | 549.18K | 1.07M | 168.29K | 105.89K | 108.11K | 0 |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 783.16K | 587.78K | 648.51K | 883.73K | 694.11K | 1.02M | 550.74K | 424.45K | 444.53K | 945.16K | 1.39M | 155.29K | 136.55K | 148.41K | 523.52K | 32.26K | -18.25K | 32.4K | 10.51K | 0 |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 1.4M | 25.41K | 4.15M | 4.66M | 1.41M | 32.56K | 2.83M | 3.52M | 25K | 75.46K | 483.47K | 0 | 2.62M | 2.61M | 0 | 1.04M | 186.54K | 73.49K | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.94K | -13.1K | 0 | -25.66K | 0 | 0 | 0 | 97.6K | 0 |
| Operating Income | -2.18M | -613.2K | -4.8M | -5.54M | -2.1M | -1.05M | -3.38M | -3.95M | -469.53K | -1.02M | -1.87M | -169.24K | -149.65K | -2.76M | -549.18K | -1.07M | -168.29K | -105.89K | -108.11K | 0 |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -3.76% | 41.61% | -42.18% | -40.37% | -348.17% | -2.9% | -80.53% | -2233.64% | -213.75% | 62.97% | -240.6% | 84.24% | 11.08% | -2502.95% | -407.98% | - | - | - | - | - |
| EBITDA | -2.18M | -613.2K | -4.8M | -5.54M | -2.1M | -1.05M | -3.38M | -3.95M | -509.12K | -898.54K | -1.83M | -114.36K | -144.16K | -2.76M | -488.72K | -1M | -114.29K | -50.09K | -107.55K | -3.56K |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -3.76% | 41.61% | -42.18% | -40.37% | -313.32% | -16.88% | -84.63% | -3353.52% | -253.16% | 67.4% | -274.22% | 88.6% | -26.13% | -5403.1% | -354.43% | -28099.1% | - | - | - | - |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -39.59K | 122.08K | 41.58K | 54.88K | 5.49K | 0 | 60.46K | 71.39K | 54K | 55.81K | 0 | 0 |
| EBIT | -2.18M | -613.2K | -4.8M | -5.54M | -2.1M | -1.05M | -3.38M | -3.95M | -469.53K | -1.02M | -1.87M | -2.73M | -2.74M | -2.76M | -2.89M | -1.07M | -168.29K | -105.89K | -107.55K | -3.56K |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 114.31K | 105.79K | 381.89K | 204.31K | 0 | 0 | 0 | 567 | 4 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 114.31K | 105.79K | 381.89K | 204.31K | 0 | 0 | 0 | 567 | 4 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -108.63K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.68M | 2.7M | 0 | 2.54M | 0 | 0 | -29.9K | 563 | -3.56K |
| Pretax Income | -2.29M | -613.2K | -4.8M | -5.54M | -2.1M | -1.05M | -3.38M | -3.95M | -469.53K | -1.02M | -1.87M | -54.93K | -43.86K | -2.76M | -344.86K | -1.07M | -168.29K | -105.89K | -107.55K | -3.56K |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | -25 | 0 | 850 | 13 | 63 | 0 | 1.63K | 0 | 0 | 0 | 21.08K | 19.46K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | -0.02% | -0% | -0.01% | 0% | -0.04% | 0% | 0% | 0% | -38.37% | -44.38% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -2.29M | -613.17K | -4.8M | -5.54M | -2.1M | -1.05M | -3.38M | -3.95M | -469.53K | -1.02M | -1.87M | -76K | -63.33K | -2.76M | -344.86K | -1.07M | -168.29K | -105.89K | -107.55K | -3.56K |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -8.92% | 41.62% | -42.18% | -40.34% | -348.17% | -2.91% | -80.53% | -5098.51% | -641.46% | 62.97% | -442.39% | 92.92% | 62.37% | -2502.95% | -220.66% | -30115.22% | - | - | - | - |
| Net Income (Continuing) | -2.29M | -613.17K | -4.8M | -5.54M | -2.1M | -1.05M | -3.38M | -3.95M | -469.53K | -1.02M | -1.87M | -76K | -63.33K | -2.76M | -344.86K | -1.07M | -168.29K | -105.89K | -107.55K | -3.56K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.05 | -0.02 | -0.13 | -0.15 | -0.06 | -0.03 | -0.09 | -0.11 | -0.01 | -0.03 | -1.78 | -0.03 | -0.03 | -1.18 | -0.06 | -0.03 | -0.03 | -0.00 | -0.02 | -0.00 |
| EPS Growth % | 14.09% | 43.36% | -39.34% | -36.36% | -340.91% | 1.38% | 94.76% | -237.42% | 51.47% | 97.54% | -2916.95% | -6.89% | 5.56% | - | -220.65% | - | - | - | - | - |
| EPS (Basic) | -0.05 | -0.02 | -0.13 | -0.15 | -0.06 | -0.03 | -0.09 | -0.11 | -0.01 | -0.03 | -1.78 | -0.03 | -0.03 | -1.18 | -0.06 | -0.03 | -0.03 | -0.00 | -0.02 | -0.00 |
| Diluted Shares Outstanding | 42.12M | 37.97M | 37.1M | 36.17M | 36.19M | 36.68M | 36.21M | 36.61M | 35.52M | 35.2M | 1.05M | 2.33M | 2.33M | 2.33M | 5.85M | 35.2M | 5.85M | 35.2M | 5.85M | 6.07M |
| Basic Shares Outstanding | 42.12M | 37.97M | 37.1M | 36.17M | 36.19M | 36.68M | 36.21M | 36.61M | 35.52M | 35.2M | 1.05M | 2.33M | 2.33M | 2.33M | 5.85M | 35.2M | 5.85M | 35.2M | 5.85M | 6.07M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |